✦ LIBER ✦

Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer

✍ Scribed by Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kaukel, E; Freitag, L; Digel, W; Bischoff, H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised phase II trial of docetaxel

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

A randomised clinical trial of two docet

✍ Gridelli, C; Gallo, C; Di Maio, M; Barletta, E; Illiano, A; Maione, P; Salvagni, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 195 KB

Phase I study of second-line chemotherap

✍ Mikio Oka; Minoru Fukuda; Seiji Nagashima; Masaaki Fukuda; Akitoshi Kinoshita; H 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 84 KB

A randomized phase III trial of adjuvant

✍ Yukito Ichinose 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 294 KB

A phase II trial of weekly chemotherapy

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

Irinotecan plus gemcitabine vs irinoteca

✍ Georgoulias, V; Kouroussis, C; Agelidou, A; Boukovinas, I; Palamidas, P; Stavrin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB